Seven Eight Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-77,695
Closed -$1.52M 524
2022
Q2
$1.52M Buy
77,695
+56,994
+275% +$1.35M 0.61% 30
2022
Q1
$540K Sell
20,701
-35,284
-63% -$940K 0.07% 311
2021
Q4
$1.59M Buy
+55,985
New +$1.74M 0.28% 110
2021
Q3
Sell
-111,560
Closed -$3.87M 601
2021
Q2
$3.87M Buy
+111,560
New +$3.68M 0.54% 23
2020
Q1
Sell
-88,631
Closed -$2.61M 520
2019
Q4
$2.61M Sell
88,631
-198,000
-69% -$5.38M 0.14% 230
2019
Q3
$7.62M Buy
286,631
+215,200
+301% +$6.46M 0.4% 63
2019
Q2
$2.41M Sell
71,431
-324,439
-82% -$10.5M 0.13% 231
2019
Q1
$12.7M Buy
+395,870
New +$12.2M 0.67% 37

Other funds holding ELAN

Seven Eight Capital's ELAN Position: Q3 2022 in Review

Seven Eight Capital sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 77,695 shares — an estimated $1.52M sold.

Seven Eight Capital first reported a position in ELAN in Q1 2019 and held it in 8 quarters. The position peaked at $12.7M in Q1 2019. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

  • Seven Eight Capital reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
  • Seven Eight Capital sold 77,695 Elanco Animal Health shares in Q3 2022, an estimated $1.52M.
  • Seven Eight Capital first reported a position in Elanco Animal Health in Q1 2019 and held it in 8 quarters.
  • Seven Eight Capital's Elanco Animal Health position peaked at $12.7M in Q1 2019.
  • 419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Seven Eight Capital's 13F filing for Q3 2022, filed 10 Nov 2022.